Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors

Deregulation of cell cycle, via cyclin D/CDK/pRb pathway, is frequently observed in breast cancer lending support to the development of drugs targeting the cell cycle control machinery, like the inhibitors of the cycline-dependent kinases (CDK) 4 and 6. Up to now, three CDK4/6 inhibitors have been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Piezzo, Michela, Cocco, Stefania, Caputo, Roberta, Cianniello, Daniela, Gioia, Germira Di, Lauro, Vincenzo Di, Fusco, Giuseppina, Martinelli, Claudia, Nuzzo, Francesco, Pensabene, Matilde, Laurentiis, Michelino De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554788/
https://www.ncbi.nlm.nih.gov/pubmed/32899866
http://dx.doi.org/10.3390/ijms21186479

Ejemplares similares

Ejemplares similares